Clinical Trial Update: PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301) [Phase 3]

View source ↗

Summary

This update notes that PF614 is being investigated in a Phase 3 trial (PF614-301) for acute postoperative pain and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• PF614

Snippet

Sponsor: Ensysce Biosciences | Conditions: Postoperative Pain, Acute | Phase 3 | Status: RECRUITING